Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
  • LinkedIn
  • Instagram
LetterLetters

Response

Fadi Massoud
Canadian Family Physician March 2007; 53 (3) 404;
Fadi Massoud
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

I thank Dr Lexchin for his interest in my paper published in the January issue of Canadian Family Physician.1 He had some concerns about my conclusions’ not reflecting the evidence published in the recent literature on memantine.

First, my conclusion that memantine is “effective” should be interpreted in the clinical context of its use. This medication has been mostly studied in moderate to severe stages of Alzheimer disease (AD), where the natural history is inevitable deterioration of cognitive and functional capacities and behaviour. Therapeutic expectations need to be adapted accordingly. Most clinicians would agree that mild improvement, stabilization, and slower deterioration are all acceptable objectives at this stage of AD. Considering these objectives, published clinical trials with memantine do support its clinical superiority (alone or in combination with cholinesterase inhibitors) over placebo in the moderate to severe stages of AD.

Second, memantine’s pharmacoeconomic profile has not yet been adequately assessed, as clearly stated in my paper. The paper by Reisberg et al2 showed a decrease in the time spent by caregivers supervising patients in the memantine group compared with the placebo group. How this translates in terms of cost savings and delay of institutionalization is unclear. Obviously, this issue is the most important consideration for funding organizations and is regularly evoked to justify not covering the medication.

Footnotes

  • Competing interests

    I have received grants or research support from and attended advisory board meetings for and received honoraria from the following companies: Janssen-Ortho, Lundbeck, Novartis, and Pfizer. I have received honoraria for CME events from the following companies: Janssen-Ortho, Lundbeck, and Novartis.

  • Copyright© the College of Family Physicians of Canada

References

  1. ↵
    1. Massoud F
    . Maladie d’Alzheimer. Mise à jour en 2007. Can Fam Physician 2007;53:50-4.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Reisberg B,
    2. Doody R,
    3. Stoffler A,
    4. Schmitt F,
    5. Ferris S,
    6. Mobius HJ
    . Memantine in moderate-to-severe Alzheimer’s disease. N Engl J Med 2003;348:1333-41.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Canadian Family Physician: 53 (3)
Canadian Family Physician
Vol. 53, Issue 3
1 Mar 2007
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Response
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Response
Fadi Massoud
Canadian Family Physician Mar 2007, 53 (3) 404;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Response
Fadi Massoud
Canadian Family Physician Mar 2007, 53 (3) 404;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Correction
  • Long-term monitoring needed for lichen sclerosus
  • Private-public partnerships not a threat to Canada’s health care system
Show more Letters

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • LinkedIn
  • Instagram
  • RSS Feeds

Copyright © 2025 by The College of Family Physicians of Canada

Powered by HighWire